These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26135230)

  • 21. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
    Wu Y; Loper A; Landis E; Hettrick L; Novak L; Lynn K; Chen C; Thompson K; Higgins R; Batra U; Shelukar S; Kwei G; Storey D
    Int J Pharm; 2004 Nov; 285(1-2):135-46. PubMed ID: 15488686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
    Henney HR; Fitzpatrick A; Stewart J; Runyan JD
    Clin Ther; 2008 Dec; 30(12):2263-71. PubMed ID: 19167586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained Release Ziprasidone Microparticles Prepared by Spray Drying with Soluplus® and Ethyl Cellulose to Eliminate Food Effect and Enhance Bioavailability.
    Liu W; Wang S; Lu W; Cheng Z; Jiang N
    AAPS PharmSciTech; 2019 Dec; 21(1):27. PubMed ID: 31858315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone.
    Thombre AG; Shamblin SL; Malhotra BK; Connor AL; Wilding IR; Caldwell WB
    J Control Release; 2015 Sep; 213():10-17. PubMed ID: 26130417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food.
    Kim TE; Kim JR; Jung JA; Kim MJ; Lee SY; Ko JW; Jung WT; Choi YW; Lee HJ; Kim SH; Huh W
    J Clin Pharm Ther; 2014 Apr; 39(2):192-5. PubMed ID: 24325365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation.
    Tashan E; Karakucuk A; Celebi N
    AAPS PharmSciTech; 2020 Apr; 21(3):115. PubMed ID: 32296987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study.
    Krishnan S; Zhang Y
    J Clin Pharmacol; 2008 Mar; 48(3):293-302. PubMed ID: 18285619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
    Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
    Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: a single-dose, randomized, two-way crossover study.
    Scallion R; Moore KA
    Clin Ther; 2009 Oct; 31(10):2233-41. PubMed ID: 19922894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biocomparison of Three Formulations of the S1P1 Receptor Modulator Ponesimod in Healthy Subjects.
    Juif PE; Hoch M; D'Ambrosio D; Dingemanse J
    Drugs R D; 2015 Jun; 15(2):203-10. PubMed ID: 25939333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermal sintering: a novel technique used in the design, optimization and biopharmaceutical evaluation of propranolol HCl gastric floating tablets.
    Venkata Srikanth M; Songa AS; Nali SR; Battu JR; Kolapalli VR
    Drug Dev Ind Pharm; 2014 Jan; 40(1):33-45. PubMed ID: 23317339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers.
    Lin H; Tian Y; Tian JX; Zhang ZJ; Mao GG
    Arzneimittelforschung; 2010; 60(3):162-7. PubMed ID: 20422949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers.
    Woo JS; Song YK; Hong JY; Lim SJ; Kim CK
    Eur J Pharm Sci; 2008 Feb; 33(2):159-65. PubMed ID: 18178070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of gastric pH, volume, and emptying on the food effect of ziprasidone oral absorption.
    Sutton SC; Nause R; Gandelman K
    AAPS J; 2017 Jul; 19(4):1084-1090. PubMed ID: 28321831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
    Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM
    Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
    Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.